The Experts below are selected from a list of 174 Experts worldwide ranked by ideXlab platform
E Dei-cas - One of the best experts on this subject based on the ideXlab platform.
-
Dei-Cas E. A case of Chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B. Am J Trop Med Hyg
2015Co-Authors: J Poirriez, F Breuillard, N Francois, J Fruit, B Sendid, S Gross, E Dei-casAbstract:Abstract. A case of Chromomycosis from Comoro Islands was first treated without success with high doses of oral amphotericin B (3 g per day). Treatment with itraconazole (400 mg per day) was also unsuccessful. Then, in vitro tests were done to study the susceptibility of this Fonsecaea pedrosoi strain to antifungal drugs. It was resistant to itraconazole, sensitive to 5-fluorocytosine, and the combination of 5-fluorocytosine with amphotericin B was syn-ergistic. The patient was then treated with this last combination of drugs, which seemed to be effective. The patient stopped this treatment after six months, and relapse occurred two years later. The best therapeutic strategy in cases of Chromomycosis seems to be a combination of two drugs chosen according to the results of prior antifungal susceptibility testing
-
A case of Chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B.
The American journal of tropical medicine and hygiene, 2000Co-Authors: J Poirriez, F Breuillard, N Francois, J Fruit, B Sendid, S Gross, E Dei-casAbstract:A case of Chromomycosis from Comoro Islands was first treated without success with high doses of oral amphotericin B (3 g per day). Treatment with itraconazole (400 mg per day) was also unsuccessful. Then, in vitro tests were done to study the susceptibility of this Fonsecaea pedrosoi strain to antifungal drugs. It was resistant to itraconazole, sensitive to 5-fluorocytosine, and the combination of 5-fluorocytosine with amphotericin B was synergistic. The patient was then treated with this last combination of drugs, which seemed to be effective. The patient stopped this treatment after six months, and relapse occurred two years later. The best therapeutic strategy in cases of Chromomycosis seems to be a combination of two drugs chosen according to the results of prior antifungal susceptibility testing.
J Poirriez - One of the best experts on this subject based on the ideXlab platform.
-
Dei-Cas E. A case of Chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B. Am J Trop Med Hyg
2015Co-Authors: J Poirriez, F Breuillard, N Francois, J Fruit, B Sendid, S Gross, E Dei-casAbstract:Abstract. A case of Chromomycosis from Comoro Islands was first treated without success with high doses of oral amphotericin B (3 g per day). Treatment with itraconazole (400 mg per day) was also unsuccessful. Then, in vitro tests were done to study the susceptibility of this Fonsecaea pedrosoi strain to antifungal drugs. It was resistant to itraconazole, sensitive to 5-fluorocytosine, and the combination of 5-fluorocytosine with amphotericin B was syn-ergistic. The patient was then treated with this last combination of drugs, which seemed to be effective. The patient stopped this treatment after six months, and relapse occurred two years later. The best therapeutic strategy in cases of Chromomycosis seems to be a combination of two drugs chosen according to the results of prior antifungal susceptibility testing
-
A case of Chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B.
The American journal of tropical medicine and hygiene, 2000Co-Authors: J Poirriez, F Breuillard, N Francois, J Fruit, B Sendid, S Gross, E Dei-casAbstract:A case of Chromomycosis from Comoro Islands was first treated without success with high doses of oral amphotericin B (3 g per day). Treatment with itraconazole (400 mg per day) was also unsuccessful. Then, in vitro tests were done to study the susceptibility of this Fonsecaea pedrosoi strain to antifungal drugs. It was resistant to itraconazole, sensitive to 5-fluorocytosine, and the combination of 5-fluorocytosine with amphotericin B was synergistic. The patient was then treated with this last combination of drugs, which seemed to be effective. The patient stopped this treatment after six months, and relapse occurred two years later. The best therapeutic strategy in cases of Chromomycosis seems to be a combination of two drugs chosen according to the results of prior antifungal susceptibility testing.
Benoit Barrou - One of the best experts on this subject based on the ideXlab platform.
-
Unique case report of a Chromomycosis and Listeria in soft tissue and cerebellar abscesses after kidney transplantation
BMC Infectious Diseases, 2017Co-Authors: J. Tourret, N. Benabdellah, N. Arzouk, Arnaud Fekkar, Simon Drouin, Jacques Rottembourg, Frederic Charlotte, Benoit BarrouAbstract:BackgroundChromomycosis is a rare mycotic infection encountered in tropical and subtropical regions. The disease presents as a slowly-evolving nodule that can become infected with bacteria. Here, we describe a unique association of abscesses caused by a Chromomycosis and Listeria monocytogenes in a kidney transplant recipient, and didactically expose how the appropriate diagnosis was reached.Case presentationA 49-year old male originating from the Caribbean presented a scalp lesion which was surgically removed in his hometown where it was misdiagnosed as a sporotrichosis on histology, 3 years after he received a kidney transplant. He received no additional treatment and the scalp lesion healed. One year later, an abscess of each thigh due to both F. pedrosoi and L. monocytogenes was diagnosed in our institution. A contemporary asymptomatic cerebellar abscess was also found by systematic MRI. An association of amoxicillin and posaconazole allowed a complete cure of the patient without recurring to surgery. Histological slides from the scalp lesion were re-examined in our institution and we retrospectively concluded to a first localisation of the Chromomycosis. We discuss the possible pathophysiology of this very unusual association.ConclusionIn this case of disseminated listeriosis and Chromomycosis, complete cure of the patients could be reached with oral anti-infectious treatment only.
Eduardo Fonseca - One of the best experts on this subject based on the ideXlab platform.
-
Chromomycosis due to Exophiala jeanselmei in a renal transplant recipient.
European journal of dermatology : EJD, 2003Co-Authors: C. Pena-penabad, M.t. Yebra, J. Rodríguez‐lozano, Vieira, Eduardo FonsecaAbstract:Chromomycosis is a rare mycotic infection that is more frequent in tropical and subtropical regions. Dematiaceous fungi are the causal agents of this mycosis. Several cases of Chromomycosis in organ transplant recipients have been reported. We present a case of Chromomycosis by Exophiala jeanselmei in a Spanish male who had received a renal transplant several months previously, and was receiving treatment with tacrolimus, prednisone and mycophenolate mofetil. Very few cases of Chromomycosis due to Exophiala have been reported, and this is, to our knowledge, the first European case.
S Gross - One of the best experts on this subject based on the ideXlab platform.
-
Dei-Cas E. A case of Chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B. Am J Trop Med Hyg
2015Co-Authors: J Poirriez, F Breuillard, N Francois, J Fruit, B Sendid, S Gross, E Dei-casAbstract:Abstract. A case of Chromomycosis from Comoro Islands was first treated without success with high doses of oral amphotericin B (3 g per day). Treatment with itraconazole (400 mg per day) was also unsuccessful. Then, in vitro tests were done to study the susceptibility of this Fonsecaea pedrosoi strain to antifungal drugs. It was resistant to itraconazole, sensitive to 5-fluorocytosine, and the combination of 5-fluorocytosine with amphotericin B was syn-ergistic. The patient was then treated with this last combination of drugs, which seemed to be effective. The patient stopped this treatment after six months, and relapse occurred two years later. The best therapeutic strategy in cases of Chromomycosis seems to be a combination of two drugs chosen according to the results of prior antifungal susceptibility testing
-
A case of Chromomycosis treated by a combination of cryotherapy, shaving, oral 5-fluorocytosine, and oral amphotericin B.
The American journal of tropical medicine and hygiene, 2000Co-Authors: J Poirriez, F Breuillard, N Francois, J Fruit, B Sendid, S Gross, E Dei-casAbstract:A case of Chromomycosis from Comoro Islands was first treated without success with high doses of oral amphotericin B (3 g per day). Treatment with itraconazole (400 mg per day) was also unsuccessful. Then, in vitro tests were done to study the susceptibility of this Fonsecaea pedrosoi strain to antifungal drugs. It was resistant to itraconazole, sensitive to 5-fluorocytosine, and the combination of 5-fluorocytosine with amphotericin B was synergistic. The patient was then treated with this last combination of drugs, which seemed to be effective. The patient stopped this treatment after six months, and relapse occurred two years later. The best therapeutic strategy in cases of Chromomycosis seems to be a combination of two drugs chosen according to the results of prior antifungal susceptibility testing.